1. Home
  2. CDRE vs HRMY Comparison

CDRE vs HRMY Comparison

Compare CDRE & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadre Holdings Inc.

CDRE

Cadre Holdings Inc.

HOLD

Current Price

$42.80

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.82

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDRE
HRMY
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CDRE
HRMY
Price
$42.80
$39.82
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$34.50
$51.33
AVG Volume (30 Days)
289.5K
780.1K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
0.89%
N/A
EPS Growth
33.82
50.44
EPS
1.11
3.17
Revenue
$619,068,000.00
$825,944,000.00
Revenue This Year
$12.51
$20.68
Revenue Next Year
$8.21
$15.93
P/E Ratio
$38.67
$12.57
Revenue Growth
19.94
21.13
52 Week Low
$27.07
$25.52
52 Week High
$46.64
$40.93

Technical Indicators

Market Signals
Indicator
CDRE
HRMY
Relative Strength Index (RSI) 53.75 84.53
Support Level $41.56 $32.77
Resistance Level $44.08 $36.20
Average True Range (ATR) 1.35 1.21
MACD 0.03 0.36
Stochastic Oscillator 71.60 96.26

Price Performance

Historical Comparison
CDRE
HRMY

About CDRE Cadre Holdings Inc.

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: